Thank you, Madam Chair.
Since this is probably my last turn to speak, I would like to thank all of the witnesses for being here. It was both instructive and disturbing, shall we say, to see a bit of what is happening at present.
I would like to address Ms. Van Dusen and Mr. Raynaud from the Canadian Cancer Society.
I found an article dated the beginning of May that was published after the Canadian Cancer Society called publicly for the age to start breast cancer screening to be lowered to 40. That is a pretty big thing. The Canadian Cancer Society felt the need to speak out in the media because, evidently, it had not been consulted by the working group. That is what I asked the witnesses earlier to tell me by raising their hand. So you were one of those who were not consulted, since you had to go to the media to voice your request. The article reports the response your request received: “The Canadian Task Force respects the Canadian Cancer Society and its important work … We look forward to discussing the draft recommendations on screening for breast cancer from our comprehensive evidence review later this spring.”
I imagine you have not yet had any news and you are still waiting to discuss preventive health care with the Canadian Task Force.
What do you expect, since that article reported that the working group had replied that it wanted to discuss it with you?